High-flow nasal oxygen is the reference treatment in acute hypoxemic respiratory failure: Con

Over the past decade and boosted by the coronavirus disease 2019 (COVID-19) pandemic, high-flow nasal oxygen (HFNO) has been increasingly used in the intensive care unit (ICU) to treat acute hypoxemic respiratory failure (AHRF). In this review, we show that despite this wide and rapid increase in th...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Gabriel Kemoun, Alexandre Demoule
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-07-01
סדרה:	Journal of Intensive Medicine
נושאים:	Acute respiratory failure Intubation Low-income country High flow nasal cannula Patient self-inflicted lung injury Carbon emissions
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2667100X24001415
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!